BG
TMDX icon

Bellevue Group’s Transmedics TMDX Stock Holding History

Bellevue Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1M Buy
101,139
+3,254
+3% +$424K 0.24% 61
2025
Q4 		$11.9M Sell
97,885
-19,083
-16% -$2.39M 0.23% 57
2025
Q3 		$13.1M Sell
116,968
-13,549
-10% -$1.59M 0.27% 59
2025
Q2 		$17.5M Sell
130,517
-43,193
-25% -$4.74M 0.39% 51
2025
Q1 		$11.7M Sell
173,710
-19,008
-10% -$1.31M 0.26% 67
2024
Q4 		$12M Buy
192,718
+22,874
+13% +$2.13M 0.23% 76
2024
Q3 		$26.7M Sell
169,844
-31,571
-16% -$4.86M 0.43% 66
2024
Q2 		$30.3M Sell
201,415
-162,649
-45% -$19.5M 0.49% 57
2024
Q1 		$26.9M Sell
364,064
-154,826
-30% -$12.8M 0.41% 70
2023
Q4 		$41M Sell
518,890
-17,847
-3% -$1.08M 0.63% 52
2023
Q3 		$29.4M Sell
536,737
-75,876
-12% -$5.46M 0.47% 62
2023
Q2 		$51.4M Sell
612,613
-16,871
-3% -$1.29M 0.73% 41
2023
Q1 		$47.7M Sell
629,484
-52,574
-8% -$3.64M 0.69% 50
2022
Q4 		$42.1M Buy
682,058
+28,244
+4% +$1.5M 0.56% 58
2022
Q3 		$27.3M Buy
653,814
+73,927
+13% +$3.22M 0.39% 68
2022
Q2 		$18.2M Sell
579,887
-1,142
-0.2% -$30.5K 0.26% 89
2022
Q1 		$15.7M Hold
581,029
– – 0.18% 99
2021
Q4 		$11.1M Hold
581,029
– – 0.11% 112
2021
Q3 		$19.2M Sell
581,029
-148,960
-20% -$4.55M 0.2% 103
2021
Q2 		$24.2M Sell
729,989
-12,211
-2% -$338K 0.24% 101
2021
Q1 		$30.8M Buy
742,200
+100,588
+16% +$3.1M 0.33% 89
2020
Q4 		$12.8M Buy
641,612
+64,465
+11% +$954K 0.15% 111
2020
Q3 		$7.95M Buy
577,147
+152,147
+36% +$2.61M 0.11% 116
2020
Q2 		$7.62M Buy
+425,000
New +$6.65M 0.11% 116

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bellevue Group's TMDX Position: Q1 2026 in Review

Bellevue Group increased its Transmedics (TMDX) stake by 3.3% in Q1 2026, buying an estimated $424K and bringing the position to 101,139 shares worth $10.1M. The position accounts for 0.24% of the portfolio, ranked #61.

Bellevue Group first reported a position in TMDX in Q2 2020 and has held it in 24 quarters since. The position peaked at $51.4M in Q2 2023. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Bellevue Group held 101,139 shares of Transmedics worth $10.1M as of Q1 2026.
  • Bellevue Group bought 3,254 Transmedics shares in Q1 2026, an estimated $424K.
  • Transmedics made up 0.24% of Bellevue Group's portfolio in Q1 2026, its #61 holding.
  • Bellevue Group first reported a position in Transmedics in Q2 2020 and has held it in 24 quarters since.
  • Bellevue Group's Transmedics position peaked at $51.4M in Q2 2023.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.